{"id":"jinlida-granules","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a herbal granule preparation, Jinlida works through multiple bioactive compounds that collectively enhance immune regulation and reduce systemic inflammation. The formulation is designed to improve glucose metabolism and support pancreatic function, though the precise molecular targets of individual constituents remain incompletely characterized in Western pharmacological terms.","oneSentence":"Jinlida granules is a traditional Chinese medicine formulation that modulates immune function and reduces inflammation to support metabolic health.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:50:48.752Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"},{"name":"Metabolic syndrome"}]},"trialDetails":[{"nctId":"NCT06495814","phase":"PHASE2","title":"Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Fengmei Lian","startDate":"2024-07-01","conditions":"Obese Impaired Glucose Tolerance, Newly Diagnosed Obese Type 2 Diabetic Patients","enrollment":380},{"nctId":"NCT02035644","phase":"PHASE4","title":"Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2014-02","conditions":"Type 2 Diabetes, Dyslipidemia","enrollment":360}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":20,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Jinlida granules","genericName":"Jinlida granules","companyName":"Shanghai Jiao Tong University School of Medicine","companyId":"shanghai-jiao-tong-university-school-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Jinlida granules are a small molecule intervention used to study conditions such as Type 2 Diabetes, Dyslipidemia, Obese Impaired Glucose Tolerance, and Newly Diagnosed Obese Type 2 Diabetic Patients. Jinlida granules are taken three times a day with hot water, as part of clinical trials to evaluate their efficacy and safety.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}